To the Editor: The study of aminotransferase levels by Dr Watkins and colleagues1 found a high incidence of alanine aminotransferase (ALT) elevations in healthy participants who were randomized to receive medications containing acetaminophen (paracetamol); this was not found in participants randomized to placebo. We have a number of concerns with the methods used in this study.
First, the statistical methods did not include a description of sample size determination or definition of the minimal clinically important difference that the study was designed to detect.
Second, we are concerned about allocation concealment throughout the study. For example, blinding of patients may not have been effective, since the drugs were commercial products; 3 groups used all tablets but 2 groups used both tablets and caplets. There is no description of blinding of data analysts. The analysis was not performed according to intention to treat. All of these have the potential to introduce bias.2 - 3
Third, regarding results, level of significance was apparently not adjusted for multiple comparisons, which could inflate type I error. The group mean ALT values shown in Figure 2 in the article included data from participants who were taking or who had stopped medications, which does not reflect the ALT time curve after hepatic cell injury in acetaminophen users. The aspartate aminotransferase (AST) elevations followed a similar time course but were smaller (Figure 3), raising a question about the clinical significance. Repeating a test increases the chance of detecting a positive result, which could explain the 38% ALT elevation rate in the placebo group, which was tested around 14 times. Finally, consumption of alcohol by the participants was not considered.
We believe that all of these issues suggest caution in interpreting the results of this study.
Financial Disclosure: Dr Hunt reports that he chaired a multidisciplinary round table discussion on the benefits and risks of analgesia use for musculoskeletal pain that was supported by McNeil, Canada. Dr Yuan, Dr Marroon Thabane, and Dr Lehana Thabane report no disclosures.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.